These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16232198)

  • 1. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
    Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
    Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.
    Smith SL; Gugger M; Hoban P; Ratschiller D; Watson SG; Field JK; Betticher DC; Heighway J
    Br J Cancer; 2004 Oct; 91(8):1515-24. PubMed ID: 15467767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACIN1 gene is hypermethylated in early stage lung adenocarcinoma.
    Shu Y; Iijima T; Sun W; Kano J; Ishiyama T; Okubo C; Anami Y; Tanaka R; Fukai S; Noguchi M
    J Thorac Oncol; 2006 Feb; 1(2):160-7. PubMed ID: 17409846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
    Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
    Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.
    Wang H; Zhang Z; Li R; Ang KK; Zhang H; Caraway NP; Katz RL; Jiang F
    Int J Cancer; 2005 Aug; 116(2):285-90. PubMed ID: 15800916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary preinvasive neoplasia.
    Kerr KM
    J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.
    Wang T; Liang Y; Thakur A; Zhang S; Liu F; Khan H; Shi P; Wang N; Chen M; Ren H
    Clin Chim Acta; 2017 Jan; 464():118-122. PubMed ID: 27876462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
    Strazisar M; Rott T; Glavac D
    Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New WHO classification of lung adenocarcinoma and preneoplasia].
    Lantuejoul S; Rouquette I; Brambilla E; Travis WD
    Ann Pathol; 2016 Jan; 36(1):5-14. PubMed ID: 26791238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A2 protein and non-small cell lung cancer. The dual role concept.
    Hountis P; Matthaios D; Froudarakis M; Bouros D; Kakolyris S
    Tumour Biol; 2014 Aug; 35(8):7327-33. PubMed ID: 24863947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
    Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
    PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.
    Ishiyama T; Kano J; Anami Y; Onuki T; Iijima T; Morisita Y; Yokota J; Noguchi M
    Cancer Sci; 2007 Jan; 98(1):50-7. PubMed ID: 17054434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.